Practical-, Evidence- and Guideline-Directed Advances in Antimicrobial Treatment for MAC Lung Disease

Program Medium 
Internet-based program

Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period March 20, 2023 through March 20, 2025, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view activity, totaling 1.0 hours, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CME certificate.

Estimated Time to Complete Educational Activity
1.0 hours. Physicians must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CME credit.

Course Overview
In this web-based program, physicians will learn about recent developments in the management of MAC lung disease/NTM..

Release Date
March 20, 2023

Expiration Date
March 20, 2025

Intended Audience
This complimentary CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with MAC lung disease, including pulmonologists, respiratory medicine specialists, infectious disease specialists, and related clinicians.

Participation in this activity is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support
This activity is supported by an independent medical education grant from Insmed.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Chan Medical School and CMEducation Resources, LLC. The University of Massachusetts Chan Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The University of Massachusetts Chan Medical School, Office of Continuing Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Chan Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Chan Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosure
Stephen K. Field, MD,CM, FRCP(C)
Clinical Professor of Medicine Division of Respiratory Medicine
Cumming School of Medicine
University of Calgary
Calgary, Alberta, Canada

Nothing to disclose

Program Managers and Web Editor Disclosure 
Program Managers Gideon Bosker, MD and Denise Leary have nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Recognize patients and symptoms that suggest the need to evaluate and assess—microbiologically and radiographically—persons with COPD, bronchiectasis, history of TB and other co-morbid conditions that place them at high risk for acquiring MAC lung infection
  • Implement clinical strategies and adjunctive measures that improve regimen adherence for inhaled antimicrobial formulations approved for treatment of MAC lung disease; and, that ensure, once started, antimicrobial treatment plans can be adhered to and a full, planned course of antimicrobial therapy can be completed until evidence of microbial conversion is documented
  • Recognize NTM-LD- associated patient risk factors, underlying  risk conditions (e.g. bronchiectasis, COPD, previous history of TB) and approaches to reduce time to diagnostic confirmation, and initiation of guideline- and evidence based therapy
  • Identify and deploy individualized treatment goals based on patient factors and need to address risk of likely treatment resistance or failure
  • Manage medication adverse events, adherence, and course completion to improve treatment outcome
  • Communicate to patients the full spectrum of activities and challenges that must be addressed to optimize success and completion of an antimicrobial course of therapy for NTM-LD, including airway clearance, medication optimization, susceptibility testing, repeated cultures, duration of treatment, and medication adherence; adverse event management
  • Discuss the epidemiology and disease burden for NTM-LD and MAC Lung Disease based on prevalence, susceptible populations, and strategies for confirming the diagnosis of NTM-LD in the EU setting

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

  • We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
  • For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
  • We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
  • If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
  • You should check this privacy policy periodically to see whether we have made any changes.


Copyright © 2023 by CMEducation Resources, LLC All rights reserved. 

Reproduction, distribution, or translation without express written permission is strictly prohibited. 

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity. 

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.


March 20, 2023


March 20, 2025